In vitro systems for tissue engineering

被引:120
作者
Godbey, WT [1 ]
Atala, A [1 ]
机构
[1] Harvard Univ, Childrens Hosp, Sch Med, Lab Tissue Engn, Boston, MA 02115 USA
来源
REPARATIVE MEDICINE: GROWING TISSUES AND ORGANS | 2002年 / 961卷
关键词
tissue engineering; biomaterials; bioreactors;
D O I
10.1111/j.1749-6632.2002.tb03041.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Tissue engineering, by necessity, encompasses a wide array of experimental directions and scientific disciplines. In vitro tissue engineering involves the manipulation of cells in vitro, prior to implantation into the in vivo environment. In contrast, in vivo tissue engineering relies on the body's natural ability to regenerate over non-cell-seeded biomaterials. Cells, biomaterials, and controlled incubation conditions all play important roles in the construction and use of modern in vitro systems for tissue engineering. Gene delivery is also an important factor for controlling or supporting the function of engineered cells both in vitro and post implantation, where appropriate. In this review, systems involved in the context of in vitro tissue engineering are addressed, including bioreactors, cell-seeded constructs, cell encapsulation, and gene delivery. Emphasis is placed upon investigations that are more directly linked to the treatment of clinical conditions.
引用
收藏
页码:10 / 26
页数:17
相关论文
共 111 条
[1]   The growth and morphological behavior of salivary epithelial cells on matrix protein-coated biodegradable substrata [J].
Aframian, DJ ;
Cukierman, E ;
Nikolovski, J ;
Mooney, DJ ;
Yamada, KM ;
Baum, BJ .
TISSUE ENGINEERING, 2000, 6 (03) :209-216
[2]  
Alberts B., 1994, MOL BIOL CELL, P971
[3]   Engraftment of autologous retrovirally transduced hepatocytes after intraportal transplantation into nonhuman primates:: Implication for ex vivo gene therapy [J].
Andreoletti, M ;
Loux, N ;
Vons, C ;
Nguyen, TH ;
Lorand, I ;
Mahieu, D ;
Simon, L ;
Di Rico, V ;
Vingert, B ;
Chapman, J ;
Briand, P ;
Schwall, R ;
Hamza, J ;
Capron, F ;
Bargy, F ;
Franco, D ;
Weber, A .
HUMAN GENE THERAPY, 2001, 12 (02) :169-179
[4]   Autologous cell transplantation for urologic reconstruction [J].
Atala, A .
JOURNAL OF UROLOGY, 1998, 159 (01) :2-3
[5]   FORMATION OF UROTHELIAL STRUCTURES INVIVO FROM DISSOCIATED CELLS ATTACHED TO BIODEGRADABLE POLYMER SCAFFOLDS INVITRO [J].
ATALA, A ;
VACANTI, JP ;
PETERS, CA ;
MANDELL, J ;
RETIK, AB ;
FREEMAN, MR .
JOURNAL OF UROLOGY, 1992, 148 (02) :658-662
[6]   INJECTABLE ALGINATE SEEDED WITH CHONDROCYTES AS A POTENTIAL TREATMENT FOR VESICOURETERAL REFLUX [J].
ATALA, A ;
CIMA, LG ;
KIM, W ;
PAIGE, KT ;
VACANTI, JP ;
RETIK, AB ;
VACANTI, CA .
JOURNAL OF UROLOGY, 1993, 150 (02) :745-747
[7]  
Atala A., 2001, Methods of tissue engineering, V1st
[8]  
ATALA A, 2001, IN PRESS BR J UROL
[9]   Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF [J].
Bachoud-Lévi, AC ;
Déglon, N ;
Nguyen, JP ;
Bloch, J ;
Bourdet, C ;
Winkel, L ;
Rémy, P ;
Goddard, M ;
Lefaucheur, JP ;
Brugières, P ;
Baudic, S ;
Cesaro, P ;
Peschanski, M ;
Aebischer, P .
HUMAN GENE THERAPY, 2000, 11 (12) :1723-1729
[10]   THE USE OF XENOGENEIC SMALL-INTESTINAL SUBMUCOSA AS A BIOMATERIAL FOR ACHILLES-TENDON REPAIR IN A DOG-MODEL [J].
BADYLAK, SF ;
TULLIUS, R ;
KOKINI, K ;
SHELBOURNE, KD ;
KLOOTWYK, T ;
VOYTIK, SL ;
KRAINE, MR ;
SIMMONS, C .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1995, 29 (08) :977-985